289 related articles for article (PubMed ID: 31760702)
1. Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC.
Schulze AB; Schmidt LH; Heitkötter B; Huss S; Mohr M; Marra A; Hillejan L; Görlich D; Barth PJ; Rehkämper J; Evers G
Thorac Cancer; 2020 Jan; 11(1):120-129. PubMed ID: 31760702
[TBL] [Abstract][Full Text] [Related]
2. Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.
Kilvaer TK; Khanehkenari MR; Hellevik T; Al-Saad S; Paulsen EE; Bremnes RM; Busund LT; Donnem T; Martinez IZ
PLoS One; 2015; 10(8):e0134965. PubMed ID: 26252379
[TBL] [Abstract][Full Text] [Related]
3. CD66b
Cong X; Zhang Y; Zhu Z; Li S; Yin X; Zhai Z; Zhang Y; Xue Y
Cancer Med; 2020 Apr; 9(8):2761-2773. PubMed ID: 32096331
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.
Hao J; Zeltz C; Pintilie M; Li Q; Sakashita S; Wang T; Cabanero M; Martins-Filho SN; Wang DY; Pasko E; Venkat K; Joseph J; Raghavan V; Zhu CQ; Wang YH; Moghal N; Tsao MS; Navab R
Neoplasia; 2019 May; 21(5):482-493. PubMed ID: 30978569
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of cancer-associated fibroblasts and their correlation with microvessel and lymphatic vessel density in lung adenocarcinoma.
Chen L; Qin Y; Zhang T; Ding N; Chen Y; Zhang Z; Guo C
J Clin Lab Anal; 2019 May; 33(4):e22832. PubMed ID: 30737838
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of annexin A2 and cancer-associated fibroblasts in advanced non-small cell lung cancer: Implication in epithelial-mesenchymal transition and gefitinib resistance.
Ibrahim FM; Helal DS; Ali DA; Abd-Ellatif RN; Elkady AM; Sharshar R; Gharib F; Abo Elnasr M; El-Guindy DM
Pathol Res Pract; 2023 Jan; 241():154293. PubMed ID: 36586309
[TBL] [Abstract][Full Text] [Related]
7. MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer.
Chen Y; Du M; Wang J; Xing P; Zhang Y; Li F; Lu X
Oncotarget; 2016 Jul; 7(30):48432-48442. PubMed ID: 27374174
[TBL] [Abstract][Full Text] [Related]
8. Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer.
Alcaraz J; Carrasco JL; Millares L; Luis IC; Fernández-Porras FJ; Martínez-Romero A; Diaz-Valdivia N; De Cos JS; Rami-Porta R; Seijo L; Ramírez J; Pajares MJ; Reguart N; Barreiro E; Monsó E
Lung Cancer; 2019 Sep; 135():151-160. PubMed ID: 31446988
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Stromal Periostin Expression in Non-Small Cell Lung Cancer.
Ratajczak-Wielgomas K; Kmiecik A; Grzegrzołka J; Piotrowska A; Gomulkiewicz A; Partynska A; Pawelczyk K; Nowinska K; Podhorska-Okolow M; Dziegiel P
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987711
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer.
Teramoto K; Igarashi T; Kataoka Y; Ishida M; Hanaoka J; Sumimoto H; Daigo Y
Lung Cancer; 2019 Nov; 137():56-63. PubMed ID: 31546072
[TBL] [Abstract][Full Text] [Related]
11. Cancer-Associated Fibroblasts Accelerate Malignant Progression of Non-Small Cell Lung Cancer via Connexin 43-Formed Unidirectional Gap Junctional Intercellular Communication.
Luo M; Luo Y; Mao N; Huang G; Teng C; Wang H; Wu J; Liao X; Yang J
Cell Physiol Biochem; 2018; 51(1):315-336. PubMed ID: 30453281
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts.
Masuda T; Nakashima T; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
J Cell Mol Med; 2019 Apr; 23(4):2984-2994. PubMed ID: 30734495
[TBL] [Abstract][Full Text] [Related]
13. IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling.
Shintani Y; Fujiwara A; Kimura T; Kawamura T; Funaki S; Minami M; Okumura M
J Thorac Oncol; 2016 Sep; 11(9):1482-92. PubMed ID: 27287412
[TBL] [Abstract][Full Text] [Related]
14. Characterising cancer-associated fibroblast heterogeneity in non-small cell lung cancer: a systematic review and meta-analysis.
Irvine AF; Waise S; Green EW; Stuart B; Thomas GJ
Sci Rep; 2021 Feb; 11(1):3727. PubMed ID: 33580106
[TBL] [Abstract][Full Text] [Related]
15. Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer.
Kilvaer TK; Rakaee M; Hellevik T; Østman A; Strell C; Bremnes RM; Busund LT; Dønnem T; Martinez-Zubiaurre I
PLoS One; 2018; 13(2):e0192157. PubMed ID: 29415055
[TBL] [Abstract][Full Text] [Related]
16. Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling.
Ren Y; Cao L; Wang L; Zheng S; Zhang Q; Guo X; Li X; Chen M; Wu X; Furlong F; Meng Z; Xu K
Cell Death Dis; 2021 Sep; 12(10):858. PubMed ID: 34552063
[TBL] [Abstract][Full Text] [Related]
17. Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in co-culture.
Kim SH; Choe C; Shin YS; Jeon MJ; Choi SJ; Lee J; Bae GY; Cha HJ; Kim J
Anticancer Res; 2013 May; 33(5):2001-9. PubMed ID: 23645749
[TBL] [Abstract][Full Text] [Related]
18. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
[TBL] [Abstract][Full Text] [Related]
19. Relationship between stromal cells and tumor spread through air spaces in lung adenocarcinoma.
Qiu X; Chen D; Liu Y; Duan S; Zhang F; Zhang Y; Li F; Chen C; Chen Y
Thorac Cancer; 2019 Feb; 10(2):256-267. PubMed ID: 30605235
[TBL] [Abstract][Full Text] [Related]
20. Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC.
Wang S; Fan G; Li L; He Y; Lou N; Xie T; Dai L; Gao R; Yang M; Shi Y; Han X
Cancer Immunol Immunother; 2023 Jul; 72(7):2423-2442. PubMed ID: 37010552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
